Georgios N Stamatas

Title: Georgios N Stamatas: Innovator in Skin Therapeutics

Introduction

Georgios N Stamatas, based in Issy-les-Moulineaux, France, is a prominent inventor with a notable portfolio of eight patents. His expertise lies in the field of dermatological innovations, particularly in the evaluation of treatments aimed at mitigating side effects caused by cancer therapeutics.

Latest Patents

Two of Stamatas' most significant recent patents include a method for evaluating the efficacy of a composition in reducing the adverse effects of cancer therapeutics on the skin and a skin barrier preparation method suitable for infants and young children. The first patent discloses an epidermal tridimensional model that features differentiating keratinocytes in a reconstituted stratum corneum model. This innovation enables researchers to simulate chronic drug exposure, allowing for the evaluation of potential skin-related side effects caused by cancer treatments. The second patent focuses on selecting appropriate skin barrier systems tailored for infants and young children, ensuring their delicate skin remains protected.

Career Highlights

Stamatas has had an impactful career, encompassing work at leading companies in the consumer health sector, including Johnson & Johnson Consumer Inc. and Johnson & Johnson Consumer Companies, Inc. His contributions to these organizations have advanced the understanding and development of skin care products designed for sensitive users.

Collaborations

Throughout his career, Stamatas has collaborated with notable professionals in his field, including colleagues Jalil Bensaci and Thierry Oddos. Together, they have pushed the boundaries of skin care research, fostering innovations that improve patient care and enhance the quality of life for users of cancer therapeutics.

Conclusion

Georgios N Stamatas exemplifies the spirit of innovation in the realm of dermatology, addressing critical challenges faced by patients undergoing cancer treatment. His patents reflect a deep commitment to advancing skin care solutions and improving the lives of consumers, particularly the most vulnerable among us. As he continues to innovate, his contributions will undoubtedly leave a lasting impact on the industry.